Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-09

Clinical Trial Update: Optimal Treatment for Kidney Disease in HIV Infected Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the optimal treatment for kidney disease in HIV-infected adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Kidney Disease | Phase 3 | Status: WITHDRAWN